Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-22

FDA Approved: ETODOLAC — Supplemental Application (Ipca Laboratories Limited)

View source ↗

Summary

The FDA approved a supplemental application for etodolac filed by Ipca Laboratories Limited. This represents regulatory clearance for this generic NSAID product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etodolac (Etodolac)

Snippet

SUPPL AP for ETODOLAC (ETODOLAC)